Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 1,821 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Healthy Participants, Pharmacokinetic Study
Interventions: AGA2118; Drug
Lead sponsor: Angitia Incorporated Limited; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Glendale, California

Conditions: Adolescent
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 11 Years to 13 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Intraocular Melanoma, Melanoma (Skin)
Interventions: ipilimumab, Tyrosinase/gp100/MART-1 Peptides; Biological
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years to 120 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Coronary Artery Disease, Obesity
Interventions: Medium-intensity Minimally-directive Counseling; Behavioral
Lead sponsor: The Camelot Foundation; Other
Eligibility: 30 Years to 59 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2002
U.S. locations: 2
States / cities: Chicago, Illinois • Omaha, Nebraska

Conditions: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Interventions: HDMP + rituximab as a means of debulking prior to initiating venetoclax.; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: Not listed
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Asthma, Obesity
Interventions: DGA Diet, MCT Diet, KETO Diet; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Healthy Subjects, Mental Health Issue
Interventions: Music composition / edition, Photography composition / edition; Behavioral
Lead sponsor: New York University; Other
Eligibility: 13 Years to 16 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Brooklyn, New York • New York, New York

Conditions: Influenza A
Interventions: LD Sing2016 M2SR H3N2 influenza vaccine, MD Sing2016 M2SR H3N2 influenza vaccine, HD Sing2016 M2SR H3N2 influenza vaccine, LD Bris10 M2SR H3N2 influenza vaccine, Placebo; Biological · Other
Lead sponsor: FluGen Inc; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 206 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 4
States / cities: Hollywood, Florida • Lenexa, Kansas • Lexington, Kentucky + 1 more

Conditions: Congestive Heart Failure, Non-ischemic Cardiomyopathy
Interventions: Triheptanoin oil; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Kidney Stones, Nephrolithiasis
Interventions: ureteroscopy, CVAC; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Knee Cartilage Defects
Interventions: CARTISTEM® + Debridement, Debridement; Biological · Procedure
Lead sponsor: Medipost, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 37
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Tempe, Arizona + 30 more

Conditions: Epilepsy, Seizure, Catamenial Epilepsy, Medically Resistant Epilepsy, Medically Resistant Seizures
Interventions: betaquik®; Dietary Supplement
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Baltimore, Maryland • Madison, Wisconsin

Conditions: HPV Infection, HPV 16 Infection, High Risk HPV, Cervical Cancer Screening, Cervical Cancer Cin Grade, Cervical Cancer (Early Detection), HPV, HPV (Human Papillomavirus)-Associated, HPV DNA, HPV Infections, Screening Test
Interventions: Q-Pad hrHPV Test System; Device
Lead sponsor: Qurasense; Industry
Eligibility: 25 Years and older · Female only
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: New Haven, Connecticut • Minneapolis, Minnesota • Akron, Ohio

Conditions: Malignant Neoplasm, Oral Pain, Stomatitis
Interventions: Best Practice, Methylene Blue; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mechanistic Self-Dehumanization Condition, Control Condition
Interventions: The Ten Item Personality Inventory, Mechanistic Self-Dehumanization Condition, Debrief, Control Condition, Clinical Interview, Self-Report Measures, Blood Draw; Other · Diagnostic Test
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 40 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Breastfeeding, SUID, SIDS
Interventions: Prenatal Safe Sleep Mobile Health (mHealth) Messaging, Prenatal Breastfeeding Mobile Health (mHealth) Messaging, Postnatal Safe Sleep Mobile Health (mHealth) Messaging, Postnatal Breastfeeding Mobile Health (mHealth) Messaging; Behavioral
Lead sponsor: Boston University; Other
Eligibility: 14 Years and older · Female only
Enrollment: 2,093 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Nicotine, E-liquid Flavors
Interventions: Nicotine 0 mg/mL, Nicotine 6 mg/mL, Nicotine 12 mg/mL, Nicotine 24 mg/mL, 'Menthol' flavor, 'Menthol/Mint' flavor, 'Green Apple' flavor, 'Watermelon' flavor, 'Unflavored'; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Pregnancy, Fertility
Interventions: Not listed
Lead sponsor: BioIncept LLC; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy Volunteers
Interventions: Placebo, Vaporized THC alone, Vaporized CBD alone, Vaporized CBD with THC; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Influenza, Otitis Media, Lower Resp Tract Infection, Encephalitic Infection, Myositis Viral, Fever
Interventions: Respiratory nasal swab; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 6 Months to 8 Years
Enrollment: 1,478 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Aurora, Colorado • Broomfield, Colorado

Conditions: Degenerative Disc Disease
Interventions: Rexlemestrocel-L + HA mixture, Saline; Drug
Lead sponsor: Mesoblast, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 40
States / cities: Phoenix, Arizona • Tucson, Arizona • Chula Vista, California + 37 more

Conditions: Prader-Willi Syndrome
Interventions: Placebo, Tesomet; Other · Drug
Lead sponsor: Saniona; Industry
Eligibility: 13 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Lansing, Michigan

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: BEA 2180 BR, Tiotropium Bromide, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years to 100 Years
Enrollment: 2,080 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 56
States / cities: Jasper, Alabama • Mobile, Alabama • Berkeley, California + 50 more

Conditions: Pregnancy Prevention
Interventions: Teen Outreach Program with Media Enhancement (TOP4ME); Behavioral
Lead sponsor: Colorado School of Public Health; Other
Eligibility: 14 Years to 18 Years
Enrollment: 852 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Denver, Colorado

Search by objective public record fields.

An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

Media-Smart Youth Program Evaluation Study

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Cardiovascular Outcomes Of Diet Counseling

Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients

Nutrition for Asthmatics with Obesity

A Music and Visual Arts Digital Intervention in Teenagers to Promote Healthy Engagement With Social Media.

Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines

Study of the Acute Effects of Triheptanoin in Heart Failure

FANS vs CVAC for Medium to Large Stones

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

Inducing Self-Dehumanization to Examine Oxytocin and Suicide Risk

Social Media and Risk Reduction Teaching-Enhanced Reach

Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes

Prognostic Value of PIF Detection in Embryo Culture Media Correlation With Pregnancy Outcome

Behavioral and Physiological Effects of THC and CBD

Evaluation of Moderate to Severe Influenza Outcomes in Children

Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome

An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

Using Social Media to Enhance the Impact of the Teen Outreach Program